Keyphrases
Breast Flap
54%
Enhanced Recovery after Surgery (ERAS®)
54%
Patient-specific
36%
Prosthesis
36%
Flap
34%
Operative
29%
Resident Education
27%
Polyetheretherketone
27%
Education Development
27%
MiR-128
27%
Perioperative Protocols
27%
Novel Technique
27%
Anal Reconstruction
27%
Perineal Hernia
27%
Patient Quality
27%
Outcomes Research
27%
Interfrontal Angle
27%
Implant Augmentation
27%
Patient Safety
27%
Immediate Dental Implant Loading
27%
Delayed Implants
27%
Craniofacial Trauma
27%
Regulatory Approval
27%
Reconstruction Surgery
27%
Lower Limb Lymphedema
27%
Rapid Implementation
27%
Randomized Controlled Trial
27%
Pathway Prototyping
27%
Metopic Synostosis
27%
Lower Extremity
27%
Objective Assessment
27%
WEE1
27%
Vascularized Lymph Node Transfer
27%
Hypotension
27%
Perianal Crohn's Disease
27%
Gene Expression
27%
Abdominal
27%
Oncologic
27%
Microsurgical Breast Reconstruction
27%
Sinus Cavity
27%
Rutile
27%
MicroRNA Expression
27%
Charcot Neuroarthropathy
27%
Severity Grading
27%
Comparing Models
27%
Medical Students
27%
Recipient Site
27%
Glioma
27%
No Significant Difference
23%
Hernia Repair
20%
Medicine and Dentistry
Implant
100%
Free Tissue Graft
57%
Enhanced Recovery After Surgery
54%
Breast Reconstruction
45%
Implant Placement
31%
Prosthesis
28%
Lymphedema
27%
Lymph Node
27%
Sacrum
27%
Patient Safety
27%
Quality Improvement
27%
Synostosis
27%
Anoplasty
27%
Hypotension
27%
Oral Implants
27%
Decision Making
27%
Arthropathy
27%
Sequela
27%
Dental Implant
27%
Reconstructive Surgery
27%
Hernia
27%
Crohn's Disease
27%
Polyetheretherketone
27%
Injury
27%
Surgical Planning
18%
Patient Population
18%
Radiation Therapy
18%
Adjuvant Therapy
18%
Hernioplasty
16%
Pelvis
13%
Paranasal Sinus
13%
Computer Assisted Tomography
12%
Mean Arterial Pressure
10%
Clinical Decision Making
9%
Morphine
9%
Photograph
9%
Opiate
9%
Vestibuloplasty
9%
Diagnosis
9%
Cancer Surgery
9%
Edema
9%
Mandible Reconstruction
9%
Fibula Graft
9%
Benign Tumor
9%
Malignant Neoplasm
9%
Postoperative Complication
8%
Infection
8%
Bradycardia
6%
Neuropathic Joint Disease
6%
Donor Site
5%
